Meta-analysis on resected pancreatic cancer: a comparison between adjuvant treatments and gemcitabine alone

Meta-analysis on resected pancreatic cancer: a comparison between adjuvant treatments and gemcitabine alone

Abstract Background Pancreatic cancer is a highly malignant tumor with a poor prognosis. Chemotherapy such as gemcitabine is still an important treatment. Gemcitabine (Gem) may prolong survival time and delay the development of recurrent disease after complete resection of pancreatic cancer. Current...

Full description

Bibliographic Details
Main Authors: Hua Chen, Ruizhi He, Xiuhui Shi, Min Zhou, Chunle Zhao, Hang Zhang, Renyi Qin
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Cancer
Subjects:
Pancreatic cancer
Gemcitabine
Chemotherapy
Meta-analysis
Online Access:http://link.springer.com/article/10.1186/s12885-018-4948-7

Similar Items

Similar Items